Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-080948

Options or other derivatives

  • President and CEO acquired 170,803 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McCarthy Sean A. President and CEO 2016-09-26 Grant or award · Stock Option (Right to Buy) +48,379 48,379 D
McCarthy Sean A. President and CEO 2016-09-26 Grant or award · Stock Option (Right to Buy) +122,424 122,424 D
Loading xslF345X03/doc1.xml…